A Senate committee today revisits the Real ID Act, which creates a federal standard for state IDs. Most folks agree it's a good idea, but no one wants to foot the expensive bill, reports Jeremy Hobson.
Senate Democrats are working to allow cheap prescription drug imports to save Americans money, but critics warn the move could have unintended consequences that'll incur higher costs than what we're paying now, reports John Dimsdale.
Tensions in Washington remain high as Democratic leaders return to the drawing board to come up with a veto-proof appropriations bill that will move toward bringing U.S. troops home. Steve Henn reports.
The U.S. government announced it no longer needs the three-year Treasury note, because the budget deficit has improved. But some market watchers are already talking about the note's resurrection. Jeff Tyler reports.
Department of Education officials are in the hot seat for allegedly favoring some lenders in the $85 billion student loan industry. Democrats are expanding their probe and will question the department head.
Something's been lost in the debate over emergency Iraq war funding and troop withdrawal deadlines. The price tag for the war is approaching $500 billion — about 10 times the advertised price. Steve Henn reports.
As the Food & Drug Administration tries to deal with the fallout from the contaminated pet food scandal, Congress has started looking at whether the agency is doing its job. Ashley Milne-Tyte reports.
Democrats say they're close to an agreement to roll the AMT off the middle class and back to its original intent: to tax the very wealthy. Republicans have promised to fight such a move, but that could push swing voters away these days, Bob Moon reports.
The FDA is trying to protect the food supply of a nation that imports more than ever with a budget that hasn't kept pace with inflation. Today lawmakers take a critical look at the situation, Jeremy Hobson reports.
